As pharma companies resume full-scale operation after the COVID-19 outbreak, the demand for large-scale peptide therapeutics contract API manufacturing is expected to increase significantly. It is ...

Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. This ...

Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals. The year 2011 was another year of transition for fine-chemical ...

Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Overview: Auditing an API CMO or any API supplier is a specialty that requires knowledge and experience that is gained through exposure to the unique attributes associated with API manufacturing. API ...

BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from ...

With a quality-by-design approach, robust processes consistently can help deliver quality product. With a quality-by-design approach, robust processes consistently deliver quality product. Small drug ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...